12/4/2024

Janusmed kön och genus

Janusmed kön och genus – Oxcarbazepin Mylan

Janusmed kön och genus är ett kunskapsstöd som tillhandahåller information om köns- och genusaspekter på läkemedelsbehandling. Kunskapsstödet är avsedd främst för hälso- och sjukvårdspersonal. Texterna är generella och ska inte ses som behandlingsriktlinjer. Det är alltid behandlande läkare som ansvarar för patientens medicinering.

För att komma till startsidan för Janusmed kön och genus och för att göra sökningar klicka här.

Tillbaka till index
A A
A A

Oxkarbazepin

Oxkarbazepin

Klass : A

Visa all info

Skriv ut

Kontakta oss

  1. Trileptal (oxcarbazepine). Summary of Product Characteristics. Swedish Medical Products Agency (MPA) {updated 2019-04-15, cited 2019-09-24].

  2. Trileptal (oxcarbazepine) DailyMed [www]. US National Library of Medicine. [updated 2019-01-04, cited 2019-09-24].

  3. Yu Y, Zhang Q, Xu W, Lv C, Hao G. Population pharmacokinetic modeling of oxcarbazepine active metabolite in Chinese patients with epilepsy. Eur J Drug Metab Pharmacokinet. 2016;41(4):345-51.

  4. Lin WW, Li XW, Jiao Z, Zhang J, Rao X, Zeng DY et al. Population pharmacokinetics of oxcarbazepine active metabolite in Chinese paediatric epilepsy patients and its application in individualised dosage regimens. Eur J Clin Pharmacol. 2019;75(3):381-392.

  5. US Food and Drug Administration. Statistical Review - TRILEPTAL (oxcarbazepine). Drugs@FDA [www]. [updated 2001-11-20, cited 2019-10-09].

  6. Besi E, Boniface DR, Cregg R, Zakrzewska JM. Comparison of tolerability and adverse symptoms in oxcarbazepine and carbamazepine in the treatment of trigeminal neuralgia and neuralgiform headaches using the Liverpool Adverse Events Profile (AEP). J Headache Pain. 2015;16:563.

  7. Grikiniene J, Volbekas V, Stakisaitis D. Gender differences of sodium metabolism and hyponatremia as an adverse drug effect. Medicina (Kaunas). 2004;40:935-42.

  8. Berghuis B, van der Palen J, de Haan GJ, Lindhout D, Koeleman BPC, Sander JW et al. Carbamazepine- and oxcarbazepine-induced hyponatremia in people with epilepsy. Epilepsia. 2017;58(7):1227-1233.

  9. Isojärvi JI, Löfgren E, Juntunen KS, Pakarinen AJ, Päivänsalo M, Rautakorpi I et al. Effect of epilepsy and antiepileptic drugs on male reproductive health. Neurology. 2004;62:247-53.

  10. Asadi-Pooya A, Farazdaghi M, Ashjazadeh N. Effects of carbamazepine on semen parameters in men with newly diagnosed epilepsy. Iran J Neurol. 2015;14(3):168-70.

  11. Svalheim S, Sveberg L, Mochol M, Taubøll E. Interactions between antiepileptic drugs and hormones. Seizure. 2015;28:12-7.

  12. Ocek L, Tarhan H, Uludağ FI, Sarıteke A, Köse C, Colak A et al. Evaluation of sex hormones and sperm parameters in male epileptic patients. Acta Neurol Scand. 2018;137(4):409-416.

  13. Wu D, Chen L, Ji F, Si Y, Sun H. The effects of oxcarbazepine, levetiracetam, and lamotrigine on semen quality, sexual function, and sex hormones in male adults with epilepsy. Epilepsia. 2018;59(7):1344-1350.

  14. Yogarajah M, Mula M. Sexual Dysfunction in Epilepsy and the Role of Anti-Epileptic Drugs. Curr Pharm Des. 2017;23(37):5649-5661.

  15. Statistikdatabas för diagnoser. Stockholm: Socialstyrelsen. 2019 [cited 2020-10-01.]

  16. Adelöw C, Andell E, Amark P, Andersson T, Hellebro E, Ahlbom A et al. Newly diagnosed single unprovoked seizures and epilepsy in Stockholm, Sweden: First report from the Stockholm Incidence Registry of Epilepsy (SIRE). Epilepsia. 2009;50:1094-101.

  17. Statistikdatabas för läkemedel. Stockholm: Socialstyrelsen. 2019 [cited 2020-03-10.]

  1. Trileptal (oxcarbazepine). Summary of Product Characteristics. Swedish Medical Products Agency (MPA) {updated 2019-04-15, cited 2019-09-24].
  2. Trileptal (oxcarbazepine) DailyMed [www]. US National Library of Medicine. [updated 2019-01-04, cited 2019-09-24].
  3. Yu Y, Zhang Q, Xu W, Lv C, Hao G. Population pharmacokinetic modeling of oxcarbazepine active metabolite in Chinese patients with epilepsy. Eur J Drug Metab Pharmacokinet. 2016;41(4):345-51.
  4. Lin WW, Li XW, Jiao Z, Zhang J, Rao X, Zeng DY et al. Population pharmacokinetics of oxcarbazepine active metabolite in Chinese paediatric epilepsy patients and its application in individualised dosage regimens. Eur J Clin Pharmacol. 2019;75(3):381-392.
  5. US Food and Drug Administration. Statistical Review - TRILEPTAL (oxcarbazepine). Drugs@FDA [www]. [updated 2001-11-20, cited 2019-10-09].
  6. Besi E, Boniface DR, Cregg R, Zakrzewska JM. Comparison of tolerability and adverse symptoms in oxcarbazepine and carbamazepine in the treatment of trigeminal neuralgia and neuralgiform headaches using the Liverpool Adverse Events Profile (AEP). J Headache Pain. 2015;16:563.
  7. Grikiniene J, Volbekas V, Stakisaitis D. Gender differences of sodium metabolism and hyponatremia as an adverse drug effect. Medicina (Kaunas). 2004;40:935-42.
  8. Berghuis B, van der Palen J, de Haan GJ, Lindhout D, Koeleman BPC, Sander JW et al. Carbamazepine- and oxcarbazepine-induced hyponatremia in people with epilepsy. Epilepsia. 2017;58(7):1227-1233.
  9. Isojärvi JI, Löfgren E, Juntunen KS, Pakarinen AJ, Päivänsalo M, Rautakorpi I et al. Effect of epilepsy and antiepileptic drugs on male reproductive health. Neurology. 2004;62:247-53.
  10. Asadi-Pooya A, Farazdaghi M, Ashjazadeh N. Effects of carbamazepine on semen parameters in men with newly diagnosed epilepsy. Iran J Neurol. 2015;14(3):168-70.
  11. Svalheim S, Sveberg L, Mochol M, Taubøll E. Interactions between antiepileptic drugs and hormones. Seizure. 2015;28:12-7.
  12. Ocek L, Tarhan H, Uludağ FI, Sarıteke A, Köse C, Colak A et al. Evaluation of sex hormones and sperm parameters in male epileptic patients. Acta Neurol Scand. 2018;137(4):409-416.
  13. Wu D, Chen L, Ji F, Si Y, Sun H. The effects of oxcarbazepine, levetiracetam, and lamotrigine on semen quality, sexual function, and sex hormones in male adults with epilepsy. Epilepsia. 2018;59(7):1344-1350.
  14. Yogarajah M, Mula M. Sexual Dysfunction in Epilepsy and the Role of Anti-Epileptic Drugs. Curr Pharm Des. 2017;23(37):5649-5661.
  15. Statistikdatabas för diagnoser. Stockholm: Socialstyrelsen. 2019 [cited 2020-10-01.]
  16. Adelöw C, Andell E, Amark P, Andersson T, Hellebro E, Ahlbom A et al. Newly diagnosed single unprovoked seizures and epilepsy in Stockholm, Sweden: First report from the Stockholm Incidence Registry of Epilepsy (SIRE). Epilepsia. 2009;50:1094-101.
  17. Statistikdatabas för läkemedel. Stockholm: Socialstyrelsen. 2019 [cited 2020-03-10.]